Community with high medical debt questions its hospitals’ charity spending

Cidara Ther­a­peu­tics an­nounced sev­er­al sweep­ing moves on Wednes­day af­ter­noon to bring an in­fluen­za drug back in-house and raise mon­ey from in­vestors to back the pro­gram.

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.)  As weight loss drugs boom in pop­u­lar­i­ty,